The full report is titled “Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy. A Subgroup Analysis of a Randomized Trial.” It is in the 18 June 2013 issue of Annals of Internal Medicine (volume 159, pages 861-868). The authors are K.W. Mahaffey, D. Wojdyla, G.J. Hankey, H.D. White, C.C. Nessel, J.P. Piccini, M.R. Patel, S.D. Berkowitz, R.C. Becker, J.L. Halperin, D.E. Singer, R.M. Califf, K.A.A. Fox, G. Breithardt, and W. Hacke.
Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy. Ann Intern Med. 2013;158:I–28. doi: https://doi.org/10.7326/0003-4819-158-12-201306180-00001
Download citation file:
Published: Ann Intern Med. 2013;158(12):I-28.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use